Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans

Citation
As. Ward et al., Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans, BEHAV PHARM, 9(7), 1998, pp. 577-586
Citations number
38
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BEHAVIOURAL PHARMACOLOGY
ISSN journal
09558810 → ACNP
Volume
9
Issue
7
Year of publication
1998
Pages
577 - 586
Database
ISI
SICI code
0955-8810(199811)9:7<577:KATCRB>2.0.ZU;2-Q
Abstract
Attenuation of hypothalamo pituitary-adrenal (HPA) function in laboratory r odents has been found to reduce the reinforcing effects of cocaine. To exam ine whether attenuation of HPA function reduces the effects of cocaine in h umans, one female and seven male 'crack' cocaine abusers were pretreated wi th three doses of ketoconazole (0, 600, 1200 mg), an inhibitor of adrenocor ticoid biosynthesis, 1 h before receiving cocaine. Three doses of smoked co caine (0, 12, 50 mg) were administered in counterbalanced order under each ketoconazole condition. Ketoconazole dose-dependently reduced cocaine-induc ed cortisol, but not adrenocorticotropin (ACTH) release, and attenuated the cocaine-induced increase in heart rate and blood pressure. Plasma ACTH lev els were more predictive of blood pressure changes than either cocaine or c ortisol levels. Suppression of cortisol secretion was not associated with a reduction in ratings of the subjective effects of cocaine. These results s upport a role for the HPA axis in the cardiovascular effects of cocaine, bu t do not support a role for the HPA axis in the subjective effects of cocai ne. To the extent that self-administration can be predicted by subjective e ffects, these results further argue that the HPA axis does not play a criti cal role in cocaine self-administration by humans. Behav Pharmacol 1998; 9: 577-586 (C) 1998 Lippincott Williams & Wilkins.